MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 73.2 ¤295,166 NL
RO.CH Roche Holding Ltd 58.7 ¤270,224 CH
NOVO.B.DK Novo Nordisk A/S Class B 71.1 ¤251,481 DK
AZN.GB AstraZeneca PLC 66.2 ¤250,932 GB
OR.FR L'Oreal S.A. 52.1 ¤246,465 FR

Five Smallest Companies
Symbol Name Grade Market Cap Country
SGE.GB Sage Group plc 58.9 ¤14,226 GB
CARL.B.DK Carlsberg AS Class B 52.3 ¤15,808 DK
LIFCO.B.SE Lifco AB Class B 43.9 ¤16,580 SE
INDU.C.SE Industrivarden AB Class C 61.4 ¤17,098 SE
A5G.IE AIB Group plc 73.3 ¤17,819 IE

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 73.2 32 NL
ACN Accenture Plc Class A 62.6 31 IE
DNB.NO DNB Bank ASA 66.3 28 NO
ALV.DE Allianz SE 54.8 27 DE
NOVO.B.DK Novo Nordisk A/S Class B 71.1 27 DK
ASSA.B.SE ASSA ABLOY AB Class B 53.8 26 SE
TEL TE Connectivity plc 55.3 25 IE
ETN Eaton Corp. Plc 56.6 24 IE
VOLV.B.SE Volvo AB Class B 45.4 24 SE
IFX.DE Infineon Technologies AG 43.8 23 DE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤69,778
Median Market Cap ¤41,627
Avg. 3 Mo. Dollar Vol. ¤146,630,789
Avg. 3 Mo. Trading Vol. 3,408,966
Last Rebalance Date 03/24/2025
Companies Replaced 35
Biggest Sector Increase Consumer Staples
Biggest Sector Decrease Energy

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 16.0
Forward P/E Ratio (12 Mo.) 13.6
Price/Book Ratio 3.1
Avg. Revenue Chg. - 3 Yr 31.3%
Avg. Op. Income Chg. - 3 Yr. 41.1%
Avg. EPS Growth - 3 Yr. 14.1%
Avg. EPS Growth - 1 Yr. 14.6%
Avg. Operating Margin 19.0%
Avg. LT Debt to Total Capital 47.0%
Avg. Return on Equity 18.0%
Dividend Yield 2.7%
Index Average Grade
Europe 100 Index 57.38
Country Breakdown
United Kingdom 17.0%
Sweden 14.0%
Ireland 11.0%
Switzerland 11.0%
Germany 10.0%
Spain 6.0%
Italy 6.0%
Netherlands 6.0%
France 6.0%
Denmark 4.0%
Finland 2.0%
Austria 2.0%
Norway 2.0%
Belgium 1.0%
Czech Republic 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE